AJA Health and Wellness Inc.

C$0.04As of Sun 8 Nov 2026, 12:00 UTC

TSXV:AJAHealthcare

Country Canada

PE (Fwd) —

TSR 10Y CAGR —

Div yield —

ROE —

Health Information Services

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap C$3.034M

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

$0.0377

—

7.80%

—

TTM

FYE 31 Dec CAD

FY2022

FY2023

FY2024E

FY2025E

Trend

10Y

Peers

0.500

Revenue$M

—

0.588

0.500

0.462

0.444

(14.85%)

—

(14.85)

Revenue growth%

—

(14.85)

(7.72)

(3.94)

(14.85)

—

48.54

Gross margin%

—

64.20

48.54

40.71

36.80

56.37

—

(187.72)

Operating margin%

—

(106.44)

(187.72)

(100.00)

(147.08)

—

(230.05)

Net margin%

—

(132.98)

(230.05)

(100.00)

(181.52)

—

P/E ratio (avg)x

—

EV/EBITx

—

(27.31)

FCF yield (avg)%

—

(15.22)

(14.62)

—

(165.57)

FCF margin%

—

(68.62)

(165.57)

(100.00)

(117.10)

—

0.720

FCF / Net incomex

—

0.516

0.720

—

0.618

—

ROIC%

—

Return on equity%

—

(201.84)

Return on assets%

—

(169.39)

(201.84)

(122.43)

(117.61)

(185.62)

—

(0.01)

EPS$

—

(0.01)

—

(47.32)

EPS growth%

—

(47.32)

59.89

3.94

(47.32)

—

(0.03)

Bookvalue per sh$

—

(0.02)

(0.03)

(0.04)

—

(0.01)

FCF per share$

—

(0.01)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

86.69

Shares (diluted)M

—

86.69

◌86.69

—

Buyback yield%

—

◌—

—

(0.963)

D/E ratiox

—

(0.929)

(0.963)

(0.901)

(0.914)

(0.946)

—

5.137

Enterprise value$M

—

5.599

6.043

—

LT debt$M

—

0.269

0.712

—

Peers (US$2.148M)

Cap (US$)

Unidoc Health Corp.

2.759M

—

nDatalyze Corp.

2.048M

—

Lynx Resources Corp.

1.782M

—

Telemedycyna Polska…

2.008M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(4.434)

(4.222)

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

—

Revenue growth years

—

EPS growth years

—

Dividend streakyrs

—

Op margin range%

—

$1 testx

—

Incr. ROIC%

—

AJA Health and Wellness Inc. operates a telemedicine platform and full-service travel clinics. The company offers magnesium products: for muscle relief, sleep, and athletic performance; and ioFlavin products, such as featuring over 20 unique flavonoids with proven anti-inflammatory, antiviral, and pain relief properties. aimed at replacing opioids and reducing the risk of long-term organ damage.

Growth vs revenue

Latest

Trend

1Y CAGR

Rel growth

Revenue

$0.500M

(14.85%)

1.00×

Cost of revenue

$0.258M

22.41%

1.44×

Operating expenses

$1.182M

17.90%

1.38×

Asset mix

Trend

Other

66.13%

Cash and investments

33.87%

Reinvestment returns

No breakdown available